ALFA Finder| Management target | Revenue next 5 years |
|---|
| Revenue growth | AOV up 27% primarily due to high-ticket digital dentistry equipment. |
|---|---|
| Margins | Improving gross margins; 27-30% guidance given; high-ticket items 10-15% margin. |
| Demand visibility | Strong; clinics digitizing at low base with significant room for growth. |
| Management confidence | High; described quarter as a successful turnaround in operational efficiency. |
Growth
Average order value rose 27% while order volume grew 8%.
Outlook
Management targets reducing stockouts below 5% by December and expects 27-30% gross margins medium-term.
Risks
High stockout rates peaked at 33%; marketing spend tightened to protect margins, potentially impacting top-of-funnel growth.
Earnings Call Transcript filed with NSE, NSE: DENTALKART. Summary written with AI assistance from the document.
Vasa Denticity Ltd: key numbers
- Share price
- ₹459.60
- Market cap
- ₹763.9 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹10.24 Cr
- P/E (TTM)
- 74.6×Sector 54.5×
- Promoter holding
- 59.65%-0.54% QoQ
- FII holding
- 7.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vasa Denticity Ltd
All →Vasa Denticity Earnings Call Transcript: Key Takeaways
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
Vasa Denticity Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹87.10 Cr (+19.4% YoY), PAT ₹5.20 Cr (+8.8%), Op. EBITDA ₹7.24 Cr (+23.9%, 8.3% margin). Margin recovery driven by lower operating costs, not gross margin.
Vasa Denticity Management Change
Vasa Denticity re-appointed Independent Director Varun Chugh for five years, effective November 6, 2026. Shareholder approval at a general meeting is pending.
- Execution
- November 6, 2026 to November 6, 2031
Vasa Denticity Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 8.3% YoY
Vasa Denticity Ltd reported revenue from operations of ₹87.1 Cr (+19.5% YoY) and net profit of ₹5.2 Cr (+8.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +8.3% YoY
Vasa Denticity Board Meeting Date
VASA Denticity Limited will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.
Vasa Denticity Convertible Warrants
Vasa Denticity received NSE trading approval for 1,50,000 shares from preferential warrant conversion. Listed capital rises to ₹17.49 crore, with trading from 02 November 2026.